Navigation Links
Needle Biopsy Works Well in Diagnosing Breast Cancer
Date:12/15/2009

It's nearly as accurate a surgical method, with fewer complications, analysis finds,,,,

TUESDAY, Dec. 15 (HealthDay News) -- When it comes to diagnosing breast cancer, women and their doctors have some options, but new research suggests that the less invasive "core needle biopsy" procedure is nearly as effective in diagnosing breast cancer as an open surgical procedure is, with fewer complications than the surgical version.

The new analysis, scheduled to published in the Jan. 5 issue of Annals of Internal Medicine, looked over data from more than 100 studies comparing different biopsy methods. It found that core needle biopsy and surgical biopsy provided women with roughly similar results.

"Our findings were that any core needle biopsy has a lower risk of complications, and was almost as accurate as surgical biopsy," said the study's principal investigator, Wendy Bruening, the associate director of the ECRI Institute Evidence-based Practice Center in Plymouth Meeting, Penn.

Additionally, Bruening said that "women diagnosed with core needle biopsy were more likely to be treated with just one surgical procedure."

The U.S. government's Agency for Healthcare Research and Quality commissioned and funded the study.

Biopsies are only done after other tests, such as a mammogram, suggest that breast cancer might be present. In any biopsy procedure, a sample is taken from the suspicious area and examined for signs of malignancy.

An "open" surgical biopsy can be done using either general or local anesthesia, explained Dr. Karen Stanford, a surgeon at the Brooklyn Hospital Center in New York City. During this procedure a scalpel is used to open the skin so that the sample can be taken. Because it's a surgical procedure, scarring is a likely complication.

Core needle biopsy, on the other hand, uses a large needle with a hollow center to draw out a "core" sample from the suspicious lesion. This procedure is done using local anesthesia, Stanford said.

The 107 studies included in Bruening's analysis examined more than 57,000 breast lesions.

Although the researchers felt that many of the studies didn't meet the standards to provide a high level of evidence, they were generally large and consistent enough to conclude that the results indicate that core needle biopsy is nearly as accurate as a surgical biopsy.

The researchers found that the rate of complications for core needle biopsy was less than 1 percent while surgical biopsy complication rates were between 2 and 10 percent.

"No biopsy method is completely accurate, but the available methods are close in accuracy," said Bruening, who added, "Women usually prefer core needle biopsy."

And, most women have the option of having core needle biopsy, said Stanford, who noted that core needle biopsy is her preferred procedure.

"Most of the time, core needle biopsy is reliable enough to gather information about the diagnosis, and it may be the only procedure that women need because most breast biopsies are negative. For that reason, if we can do a minimal procedure, it's best for patients," said Stanford.

Bruening and her colleagues recommended that women talk with their doctors about which option might be best for them.

More information

The American Cancer Society explains the different tests used to diagnose breast cancer.



SOURCES: Wendy Bruening, Ph.D., associate director, ECRI Institute Evidence-Based Practice Center, Plymouth Meeting, Pa.; Karen Stanford, M.D., surgeon, The Brooklyn Hospital Center, New York City; Jan. 5, 2010, Annals of Internal Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Advances in drug screening: building a better haystack for the needles of tomorrow
2. Microneedles enhance drug administration through skin
3. No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones
4. Revolutionary Therapy: Needle-Free Technology for the Treatment Of Blinding Eye Disease
5. Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber
6. Special Purpose Needles Market to Reach $3.7 Billion by 2015, According to New Report by Global Industry Analysts, Inc
7. New Statistical Model Could Cut Needless Breast Biopsies
8. 11-gauge needle better than 14-gauge in breast biopsy
9. New Vertebral Biopsy Needle Features Exclusive Cutting Cannula
10. Goodbye needle, hello smoothie
11. Medical International Technology Inc. "MIT" Announces that it has received a US Patent for its Needle-Free Jet-Injector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 2017 , ... Students interested in video can get a jump start on ... earn a $1,000 scholarship and have his or her video posted on the GenCure ... May 31, with the winner announced on June 9. , The competition is designed ...
(Date:1/19/2017)... PA (PRWEB) , ... January 19, 2017 , ... Allegheny ... experience of patients who seek access to the Network’s programs and services in the ... primary or specialty care appointments will be offered one for that same afternoon. ...
(Date:1/19/2017)... ... January 19, 2017 , ... For ... serves Lawrenceville, New Jersey and the surrounding area, is inaugurating a charity ... (ALS), more commonly known as Lou Gehrig's disease or motor neurone disease, is ...
(Date:1/19/2017)... ... 2017 , ... For the second consecutive year, all five ... have earned “Top Doctor” awards. Dr. Mark Leondires, Dr. Spencer Richlin, Dr. Joshua ... by their peers for the 2017 list based on their exceptional patient care ...
(Date:1/19/2017)... ... , ... The 21st Century Cures Act’s Impact on Medical Devices:, What You ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do ... this year? , The passage of the act means devicemakers will be scrambling to ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan 18, 2017 Research and Markets ... by Product, by End User - Global Opportunity Analysis and Industry Forecast, ... ... 2015 and is expected to reach $5,491 million by 2022, growing at ... North America was the leading regional market in global ...
(Date:1/18/2017)... SAN JOSE, Calif. , Jan. 18, 2017  Adaptive ... machines, announced today a new partnership with Hyatt Place ... guests by providing ASTI LectroFan sleep therapy machines in ... "Obviously one of the most important parts of having ... Wicks , general manager of Hyatt Place Nashville/Downtown. "We,re ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... company specializing in the development and commercialization of regenerative ... and organs, recently reported the Company,s operating results for ... As the Company described in its recent ... year of substantial accomplishments. The Company,s contract laboratory completed ...
Breaking Medicine Technology: